Benefit Plans (Tables)

3 Months Ended

Dec. 28, 2013

A summary of the Company’s RSU activity and related information for the three months ended December 28, 2013, is as follows:


	Number of RSUs (in thousands)			Weighted- Average Grant Date Fair Value		Aggregate Intrinsic Value (in millions)
Balance at September 28, 2013		13,326		$	435.70
RSUs granted		6,183		$	491.93
RSUs vested		(2,256	)	$	379.23
RSUs cancelled		(216	)	$	461.35

Balance at December 28, 2013		17,037		$	463.23	$	9,543

Stock Option and Related Information

A summary of the Company’s stock option activity and related information for the three months ended December 28, 2013, is as follows:


	Outstanding Options
	Number of Options (in thousands)			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in millions)
Balance at September 28, 2013		4,094		$	139.65
Options granted		1		$	66.26
Options exercised		(1,308	)	$	102.86

Balance at December 28, 2013		2,787		$	156.89		1.2	$	1,124

Exercisable at December 28, 2013		2,768		$	157.56		1.1	$	1,114
Expected to vest after December 28, 2013		19		$	58.03		7.6	$	10

Summary of Share-Based Compensation Expense

The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three months ended December 28, 2013 and December 29, 2012 (in millions):


	Three Months Ended
	December 28, 2013		December 29, 2012
Cost of sales	$	109	$	85
Research and development		289		224
Selling, general and administrative		283		236

Total share-based compensation expense	$	681	$	545